HIGHLIGHTS
- who: Alessandra Amendolare and colleagues from the Department of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Bari, Italy have published the Article: The Underestimated Role of the p53 Pathway in Renal Cancer, in the Journal: Cancers 2022, 5733 of /2022/
- what: Among cancers showing a low rate of p53 mutations and poor response to conventional therapies, RCC represents an extraordinary example of the importance of p53 pathway alter- 11 of 15 ations in therapy resistance.
- future: P53 and its isoforms are key factors in mediating cell response and cell sensitivity to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.